Cargando…

The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study

AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Langenberger, Benedikt, Baier, Natalie, Hanke, Frank‐Christian, Fahrentholz, Jacqueline, Gorny, Christina, Sehlen, Stephanie, Reber, Katrin Christiane, Liersch, Sebastian, Radomski, Ralf, Haftenberger, Jens, Heppner, Hans Jürgen, Busse, Reinhard, Vogt, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859083/
https://www.ncbi.nlm.nih.gov/pubmed/34859616
http://dx.doi.org/10.1002/nop2.1146
_version_ 1784654374281150464
author Langenberger, Benedikt
Baier, Natalie
Hanke, Frank‐Christian
Fahrentholz, Jacqueline
Gorny, Christina
Sehlen, Stephanie
Reber, Katrin Christiane
Liersch, Sebastian
Radomski, Ralf
Haftenberger, Jens
Heppner, Hans Jürgen
Busse, Reinhard
Vogt, Verena
author_facet Langenberger, Benedikt
Baier, Natalie
Hanke, Frank‐Christian
Fahrentholz, Jacqueline
Gorny, Christina
Sehlen, Stephanie
Reber, Katrin Christiane
Liersch, Sebastian
Radomski, Ralf
Haftenberger, Jens
Heppner, Hans Jürgen
Busse, Reinhard
Vogt, Verena
author_sort Langenberger, Benedikt
collection PubMed
description AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. METHODS: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi‐experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient‐month level. Once the causal effect of the intervention is estimated, cost‐effectiveness will be calculated. For cost‐effectiveness, we include all patient costs observed by the German statutory health insurance. RESULTS: The results of this study will inform about the cost‐effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system.
format Online
Article
Text
id pubmed-8859083
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88590832022-03-31 The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study Langenberger, Benedikt Baier, Natalie Hanke, Frank‐Christian Fahrentholz, Jacqueline Gorny, Christina Sehlen, Stephanie Reber, Katrin Christiane Liersch, Sebastian Radomski, Ralf Haftenberger, Jens Heppner, Hans Jürgen Busse, Reinhard Vogt, Verena Nurs Open Study Protocol AIM: To estimate the cost‐effectiveness of an intervention facilitating the early detection of adverse drug events through the means of health professional training and the application of a digital screening tool. DESIGN: Multi‐centred non‐randomized controlled trial from August 2018 to March 2020 including 65 nursing homes or home care providers. METHODS: We aim to estimate the effect of the intervention on the rate of adverse drug events as primary outcome through a quasi‐experimental empirical study design. As secondary outcomes, we use hospital admissions and falls. All outcomes will be measured on patient‐month level. Once the causal effect of the intervention is estimated, cost‐effectiveness will be calculated. For cost‐effectiveness, we include all patient costs observed by the German statutory health insurance. RESULTS: The results of this study will inform about the cost‐effectiveness of the optimized drug supply intervention and provide evidence for potential reimbursement within the German statutory health insurance system. John Wiley and Sons Inc. 2021-12-02 /pmc/articles/PMC8859083/ /pubmed/34859616 http://dx.doi.org/10.1002/nop2.1146 Text en © 2021 The Authors. Nursing Open published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Study Protocol
Langenberger, Benedikt
Baier, Natalie
Hanke, Frank‐Christian
Fahrentholz, Jacqueline
Gorny, Christina
Sehlen, Stephanie
Reber, Katrin Christiane
Liersch, Sebastian
Radomski, Ralf
Haftenberger, Jens
Heppner, Hans Jürgen
Busse, Reinhard
Vogt, Verena
The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title_full The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title_fullStr The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title_full_unstemmed The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title_short The detection and prevention of adverse drug events in nursing home and home care patients: Study protocol of a quasi‐experimental study
title_sort detection and prevention of adverse drug events in nursing home and home care patients: study protocol of a quasi‐experimental study
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859083/
https://www.ncbi.nlm.nih.gov/pubmed/34859616
http://dx.doi.org/10.1002/nop2.1146
work_keys_str_mv AT langenbergerbenedikt thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT baiernatalie thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT hankefrankchristian thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT fahrentholzjacqueline thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT gornychristina thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT sehlenstephanie thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT reberkatrinchristiane thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT lierschsebastian thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT radomskiralf thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT haftenbergerjens thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT heppnerhansjurgen thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT bussereinhard thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT vogtverena thedetectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT langenbergerbenedikt detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT baiernatalie detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT hankefrankchristian detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT fahrentholzjacqueline detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT gornychristina detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT sehlenstephanie detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT reberkatrinchristiane detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT lierschsebastian detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT radomskiralf detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT haftenbergerjens detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT heppnerhansjurgen detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT bussereinhard detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy
AT vogtverena detectionandpreventionofadversedrugeventsinnursinghomeandhomecarepatientsstudyprotocolofaquasiexperimentalstudy